Unlocking the secrets within our genetic code has given birth to the biological revolution which we are fortunate to be witnessing.
From an investment by an international consortium of around $3 billion and 10 years to sequence the first whole human genome to today – when it can be done for under $500 and in less than a day – can we dare to hope that this will soon translate into more targeted treatments for hitherto untreatable diseases, including many cancers?
Is it just a matter of time before we will all carry our genetic information in our smart phones or on smart cards?
A fantastic line up of speakers gave a series of Codex Talks at the World’s Top 50 Innovators Series at the BT Auditorium in London on 28 September 2017.
Listen to all the Codex Talks from the links below:
Dr. B. Dusty Majumdar, CMO and Vice-President, IBM Watson Health
Why is genomics becoming more relevant in cancer care and what is Watson’s role in delivering better outcomes for cancer patients?
Gordon Sanghera, CEO, Oxford Nanopore Technologies
Can we stop the spread of superbugs through real time biological surveillance across healthcare, agriculture and the public?
Dr. Yaniv Erlich, Faculty, Columbia University and CSO, MyHeritage
Can we store all of the world’s data on a pickup truck?
Francis White, Vice-President, AliveCor
Is the human being in healthcare an endangered species?
Dr. Kari Stefansson, CEO, Decode
The Genetics of Human Diversity
Rodrigo Martinez, CMO, Veritas Genetics
What will it take to sequence and interpret 1 million human genomes